Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Innovent
Biotech
Awaiting regulator verdict, Innovent posts latest psoriasis win
Innovent has posted another win for its IL-23 contender to the likes of Tremfya and Skyrizi while the company awaits a decision by Chinese regulators.
James Waldron
Oct 29, 2024 9:50am
Innovent bags another phase 3 win for next-gen Lilly GLP-1 drug
Jul 22, 2024 5:31am
Innovent looks to Chinese regulators after ph. 3 psoriasis win
May 28, 2024 7:55am
Lilly's next-gen obesity drug brings Innovent ph. 3 diabetes win
May 9, 2024 7:20am
BridgeBio, Ipsen, George Medicines and more—Chutes & Ladders
May 3, 2024 8:30am
Innovent's anti-VEGF drug matches Eylea in eye disease trial
Mar 19, 2024 10:36am